Curaleaf (OTCMKTS:CURLF) Reaches New 12-Month High – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $10.40 and last traded at $9.50, with a volume of 137328 shares changing hands. The stock had previously closed at $3.41.

Analyst Upgrades and Downgrades

Separately, Zacks Research cut shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Curaleaf currently has a consensus rating of “Buy”.

Curaleaf Stock Up 3.2%

The firm has a 50 day moving average price of $7.63 and a two-hundred day moving average price of $7.51. The company has a quick ratio of 0.74, a current ratio of 1.56 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of -24.87 and a beta of 1.51.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.51. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The business had revenue of $324.23 million for the quarter, compared to analysts’ expectations of $316.62 million. As a group, sell-side analysts expect that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.